search
Back to results

Endoscopic Detection of Dysplasia in Barrett's Esophagus

Primary Purpose

Barrett's Esophagus

Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
HRME+CVC
conventional endoscopy
Sponsored by
Göteborg University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Barrett's Esophagus focused on measuring Endoscopy, Gastrointestinal

Eligibility Criteria

20 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Presence of specialized intestinal metaplasia in biopsies from the esophagus

Exclusion Criteria:

  • Dysplasia or cancer

Sites / Locations

  • Gastrointestinal Endoscopy Unit, Sahlgrenska University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Introductory conventional endoscopy

Introductory HRME+CVC

Arm Description

Conventional endoscopy followed by HRME+CVC after 30 days.

HRME+CVC followed by conventional endoscopy after 30 days.

Outcomes

Primary Outcome Measures

Incidence of detected dysplasia by each endoscopic technique.

Secondary Outcome Measures

The yield of low- and/or high-grade dysplasia by each endoscopic technique.
The number of biopsies taken and the duration of the different endoscopic techniques.

Full Information

First Posted
September 17, 2012
Last Updated
February 7, 2014
Sponsor
Göteborg University
Collaborators
Sahlgrenska University Hospital, Sweden
search

1. Study Identification

Unique Protocol Identification Number
NCT01694511
Brief Title
Endoscopic Detection of Dysplasia in Barrett's Esophagus
Official Title
High Resolution Magnifying Endoscopy and Contrast Enhanced Imaging Versus Standard White Light Endoscopy for the Detection of Dysplasia in Barrett's Esophagus. A Prospective Blinded Cross-over Study.
Study Type
Interventional

2. Study Status

Record Verification Date
February 2014
Overall Recruitment Status
Completed
Study Start Date
November 2009 (undefined)
Primary Completion Date
November 2012 (Actual)
Study Completion Date
January 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Göteborg University
Collaborators
Sahlgrenska University Hospital, Sweden

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine whether High Resolution Magnification Endoscopy (HRME) and Computed Virtual Chromoendoscopy (CVC) with targeted biopsies is superior to conventional white light endoscopy (WLE) with 4 quadrant biopsies of the metaplastic epithelium every 1-2 cm (Seattle Protocol) for detection of pre-malignant lesions in patients with Barrett's Esophagus (BE).
Detailed Description
BE is a metaplastic mucosal transformation adjacent to the esophagogastric junction, due to chronic reflux of gastric juices, Gastro Esophageal Reflux Disease (GERD). The continuous esophageal exposure of acid- and/or bile- containing fluids leads, untreated, to chronic esophagitis. In certain patients a mucosal transformation takes place. The epithelium in the distal part of esophagus is transferred from squamous into a more intestinal-like mucosa, called Specialized Intestinal Metaplasia (SIM).Patients with BE is believed to run a higher risk of developing esophageal adenocarcinoma (EAC). EAC is a rare condition in the western society, but the prevalence is rising compared with other malignancies, and a substantial increase has been seen during the last four decades. The pathogenesis of cancer development is believed to be that SIM in some patients can undergo dysplastic transformation, from low to high grade, and from high grade dysplasia (HGD) develop into AC. Advanced EAC is associated to a poor prognosis whereas HGD or carcinoma in situ may be treated endoscopically with a favorable outcome. The need for surveillance endoscopy in order to discover early cancer lesions available to curable treatment is up against cost effectiveness and evidence level regarding screening. The conventional endoscopic (CE) surveillance algorithm for BE is standard WLE and 4 quadrant biopsies of the metaplastic epithelium every 1-2 cm above the esophagogastric junction. The development of advanced endoscopic techniques have made it possible to distinguish minimal polypoid lesions but also the microvasculature and pit-pattern structures that in certain grading systems have been associated to presence of dysplasia. Attempts have been made in exploring the benefits of advanced endoscopic technologies against standard WLE. Feasibility-studies suggests that the new techniques improves the biopsy-yield for dysplasia, however only a limited number of prospective studies exist. Study aim: To determine whether HRME and CVC with targeted biopsies is superior to conventional WLE with 4 quadrant biopsies of the metaplastic epithelium every 1-2 cm (Seattle Protocol) for detection of pre-malignant lesions in patients with BE. Primary endpoint: Incidence of detected dysplasia by each endoscopic technique. Secondary endpoints: 1.The yield of low- and/or high-grade dysplasia by each endoscopic technique. 2.The number of biopsies taken and the duration of the different endoscopic techniques. 3.The endoscopic prediction capability of present dysplasia compared to histopathology for HRME. Statistical power: Based on the primary endpoint, the amount of dysplasia in a Barrett-population is approximately 10%. We calculated a raise in positive yield with using advanced endoscopy to 8%. At p<0,05 and a power of 80% the need for 105 patients. Setting: Tertiary referral high volume endoscopy center at Sahlgrenska University Hospital, Sweden.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Barrett's Esophagus
Keywords
Endoscopy, Gastrointestinal

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
111 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Introductory conventional endoscopy
Arm Type
Active Comparator
Arm Description
Conventional endoscopy followed by HRME+CVC after 30 days.
Arm Title
Introductory HRME+CVC
Arm Type
Active Comparator
Arm Description
HRME+CVC followed by conventional endoscopy after 30 days.
Intervention Type
Procedure
Intervention Name(s)
HRME+CVC
Intervention Description
High resolution magnification endoscopy with computed virtual chromoendoscopy and directed biopsy
Intervention Type
Procedure
Intervention Name(s)
conventional endoscopy
Intervention Description
Conventional white light endoscopy with four-quadrant biopsy
Primary Outcome Measure Information:
Title
Incidence of detected dysplasia by each endoscopic technique.
Time Frame
Up to 36 months.
Secondary Outcome Measure Information:
Title
The yield of low- and/or high-grade dysplasia by each endoscopic technique.
Time Frame
Up to 36 months.
Title
The number of biopsies taken and the duration of the different endoscopic techniques.
Time Frame
Up to 36 months.
Other Pre-specified Outcome Measures:
Title
The endoscopic prediction capability of present dysplasia compared to histopathology for HRME.
Time Frame
Up to 36 months.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Presence of specialized intestinal metaplasia in biopsies from the esophagus Exclusion Criteria: Dysplasia or cancer
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anders F Edebo, MD, PhD
Organizational Affiliation
Dept. Gastrosurgical Research and Education, Inst. Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden
Official's Role
Study Director
Facility Information:
Facility Name
Gastrointestinal Endoscopy Unit, Sahlgrenska University Hospital
City
Gothenburg
ZIP/Postal Code
S-41345
Country
Sweden

12. IPD Sharing Statement

Citations:
PubMed Identifier
25499989
Citation
Bratlie SO, Johnsson E, Jonsson C, Fandriks L, Edebo A. Multiple-Band Imaging Provides Better Value Than White-light Endoscopy in Detection of Dysplasia in Patients With Barrett's Esophagus. Clin Gastroenterol Hepatol. 2015 Jun;13(6):1068-74.e2. doi: 10.1016/j.cgh.2014.12.007. Epub 2014 Dec 11.
Results Reference
derived

Learn more about this trial

Endoscopic Detection of Dysplasia in Barrett's Esophagus

We'll reach out to this number within 24 hrs